109176514	109176514	CD	B-NP	O
|	|	NN	I-NP	O
TBMC	TBMC	NN	I-NP	O
|	|	NN	I-NP	O
45975339	45975339	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5237079	5237079	CD	B-NP	O
|	|	CC	I-NP	O
2/23/2005	2/23/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RESPIRATORY	RESPIRATORY	NNP	I-NP	I-protein
DISTRESS	DISTRESS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/3/2005	9/3/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2005	10/6/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DOUGLAS	DOUGLAS	NNP	B-NP	O
SANTO	SANTO	NNP	I-NP	O
FEATHEROFF	FEATHEROFF	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
transferred	transfer	VBD	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
Service	Service	NNP	I-NP	O
mid	mid	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Respiratory	Respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
bronchospastic	bronchospastic	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
nonischemic	nonischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
PAF	PAF	NN	I-NP	B-protein
,	,	,	O	O
peak	peak	JJ	B-NP	O
flows	flow	NNS	I-NP	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
to	to	TO	B-PP	O
175	175	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
previous	previous	JJ	B-NP	O
nonischemic	nonischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
most	most	JJS	B-NP	O
recent	recent	JJ	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4/11/04	4/11/04	CD	B-NP	O
as	as	RB	I-NP	O
well	well	RB	I-NP	O
as	as	IN	I-NP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
three	three	CD	B-NP	O
or	or	CC	I-NP	O
four	four	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
reported	report	VBN	I-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
friend	friend	NN	I-NP	O
's	's	POS	B-NP	O
house	house	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
acutely	acutely	RB	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
EMS	EMS	NNP	B-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
per	per	IN	B-PP	O
report	report	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
tripod	tripod	NN	I-NP	O
position	position	NN	I-NP	O
,	,	,	O	O
sweaty	sweaty	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
IVF	IVF	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
several	several	JJ	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
actually	actually	RB	B-ADVP	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
field	field	NN	B-NP	O
.	.	.	O	O

Shortly	Shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
distress	distress	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
desaturated	desaturate	VBD	B-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
urgently	urgently	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
intubation	intubation	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
secretions/emesis	secretions/emesis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
secretions	secretion	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
IVF	IVF	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
consistent	consistent	JJ	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
591	591	CD	B-NP	O
,	,	,	O	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
204	204	CD	B-NP	O
on	on	IN	B-PP	O
4/11/04	4/11/04	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
notable	notable	JJ	I-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
CK	CK	NN	B-NP	O
of	of	IN	B-PP	O
115	115	CD	B-NP	O
and	and	CC	O	O
MB	MB	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
2.8	2.8	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.62	0.62	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
11.7	11.7	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ABG	ABG	NN	I-NP	O
post	post	NN	I-NP	O
intubation	intubation	NN	I-NP	O
was	be	VBD	B-VP	O
7.4	7.4	CD	B-NP	O
/	/	SYM	B-NP	O
54/453	54/453	CD	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-ADVP	O
above	above	RB	I-ADVP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
,	,	,	I-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
nonischemic	nonischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NN	B-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Flovent	Flovent	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
,	,	,	O	O
multivitamins	multivitamin	NNS	B-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Serevent	Serevent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Valium	Valium	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Metoprolol	Metoprolol	NN	B-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
gets	get	VBZ	B-VP	O
bronchospasm	bronchospasm	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
presently	presently	RB	B-ADVP	O
smokes	smoke	VBZ	B-VP	O
cigarettes	cigarette	NNS	B-NP	O
approximately	approximately	RB	I-NP	O
half	half	PDT	I-NP	O
a	a	DT	I-NP	O
pack	pack	NN	I-NP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
pack	pack	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
x	x	SYM	O	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
drinks	drink	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ARRIVAL	ARRIVAL	NNP	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
of	of	IN	B-PP	O
100.1	100.1	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
53	53	CD	B-NP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
150/90	150/90	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
initial	initial	JJ	B-NP	O
vent	vent	NN	I-NP	O
settings	setting	NNS	I-NP	O
included	include	VBD	B-VP	O
assist	assist	NN	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
tidal	tidal	JJ	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
500	500	CD	B-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
FIO2	FIO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Exam	Exam	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
of	of	IN	B-PP	O
8	8	CD	B-NP	O
and	and	CC	I-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
reactive	reactive	JJ	B-NP	O
pupils	pupil	NNS	I-NP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
on	on	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
irregular	irregular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
3/6	3/6	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
abdomen	abdoman	NNS	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
warm	warm	JJ	B-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
notable	notable	JJ	B-NP	B-protein
labs	lab	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
as	as	RB	B-ADJP	O
above	above	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CCU	CCU	NN	I-NP	O
course	course	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
summarized	summarize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pump	pump	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
had	have	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
and	and	CC	B-PP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
CCU	CCU	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
diuresed	diurese	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
4.7	4.7	CD	I-NP	O
liters	liter	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
went	go	VBD	B-VP	O
down	down	RB	B-ADVP	O
6	6	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
of	of	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
still	still	RB	B-ADVP	O
appeared	appear	VBD	B-VP	O
somewhat	somewhat	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBN	B-VP	O
to	to	TO	B-PP	O
despite	despite	IN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
possibly	possibly	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
trending	trend	VBG	I-VP	O
downward	downward	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
medical	medical	JJ	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
,	,	,	O	O
longstanding	longstanding	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
captopril	captopril	NN	B-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
amlodipine	amlodipine	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
o	o	IN	B-PP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
IV	IV	CD	I-NP	O
with	with	IN	B-PP	O
switching	switch	VBG	B-VP	O
to	to	TO	B-PP	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ABG	ABG	NN	I-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
retention	retention	NN	I-NP	O
that	that	WDT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
continued	continue	VBD	B-VP	O
levalbuterol	levalbuterol	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Atrovent	Atrovent	NNP	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
start	start	VB	I-VP	O
a	a	DT	B-NP	O
steroid	steroid	JJ	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
ACE	ACE	NN	I-NP	O
,	,	,	O	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
five-day	five-day	JJ	B-NP	O
stay	stay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
.	.	.	O	O

Briefly	Briefly	NNP	B-NP	O
,	,	,	O	O
summarized	summarize	VBD	B-VP	O
her	her	PRP$	B-NP	O
floor	floor	NN	I-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
problems	problem	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pump	pump	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
diuresed	diurese	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
what	what	WP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
goal	goal	JJ	I-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
between	between	IN	B-PP	O
82	82	CD	B-NP	O
and	and	CC	I-NP	O
84	84	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
accomplish	accomplish	VB	I-VP	O
this	this	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	FW	B-ADVP	O
p.o.	p.o.	FW	I-ADVP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
initiate	initiate	VB	I-VP	O
any	any	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
drips	drip	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
attempted	attempt	VBD	B-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
her	her	PRP$	B-NP	O
down	down	NN	I-NP	O
to	to	TO	B-PP	O
euvolemic	euvolemic	JJ	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
84	84	CD	I-NP	O
kg	kg	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
30	30	CD	I-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
rate	rate	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
130s	130	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
diltiazem	diltiazem	NN	I-NP	O
IV	IV	CD	I-NP	O
drip	drip	NN	I-NP	O
titrated	titrate	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	B-DNA
rate	rate	NN	I-NP	I-DNA
below	below	IN	B-PP	I-DNA
100	100	CD	B-NP	I-DNA
,	,	,	O	O
maximal	maximal	JJ	B-NP	O
rate	rate	NN	I-NP	O
reached	reach	VBN	B-VP	O
140	140	CD	B-NP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
switched	switch	VBD	B-VP	O
to	to	TO	I-VP	O
diltiazem	diltiazem	VB	I-VP	O
drip	drip	NN	B-NP	O
over	over	RP	B-PRT	O
to	to	TO	B-VP	O
diltiazem	diltiazem	VB	I-VP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
eventually	eventually	RB	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
sequentially	sequentially	RB	I-VP	O
brought	bring	VBN	I-VP	O
down	down	RB	B-ADVP	O
later	later	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
started	start	VBD	B-VP	O
digoxin	digoxin	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
heparin	heparin	NN	B-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
decided	decide	VBD	B-VP	O
that	that	DT	B-NP	O
electrical	electrical	JJ	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
optimal	optimal	JJ	B-ADJP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
so	so	IN	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
chemically	chemically	RB	I-VP	O
cardioverted	cardioverte	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
dofetilide	dofetilide	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
Tikosyn	Tikosyn	NN	B-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
initiated	initiate	VBD	B-VP	O
the	the	DT	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
dofetilide	dofetilide	NN	B-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
first	first	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
loading	loading	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
250	250	CD	B-NP	O
mcg	mcg	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
with	with	IN	B-PP	O
500	500	CD	B-NP	O
mcg	mcg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
watched	watch	VBN	I-VP	O
carefully	carefully	RB	B-ADVP	O
with	with	IN	B-PP	O
EKGs	EKG	NNS	B-NP	B-protein
before	before	IN	B-PP	O
every	every	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
dofetilide	dofetilide	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
torsade	torsade	FW	B-NP	O
de	de	FW	I-NP	O
pointes	pointes	FW	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
kept	keep	VBD	B-VP	O
her	her	PRP$	B-NP	O
magnesium	magnesium	NN	I-NP	O
well	well	RB	B-VP	O
repleted	replete	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
chemical	chemical	JJ	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
and	and	CC	O	O
went	go	VBD	B-VP	O
back	back	RB	B-ADVP	O
into	into	IN	B-PP	O
mostly	mostly	RB	B-NP	O
sinus	sinus	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
too	too	RB	B-NP	O
much	much	JJ	I-NP	O
ectopy	ectopy	NN	I-NP	O
or	or	CC	O	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
decrease	decrease	VB	I-VP	O
her	her	PRP$	B-NP	O
diltiazem	diltiazem	NN	I-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
small	small	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
leaks	leak	VBZ	B-VP	O
that	that	IN	B-SBAR	O
eventually	eventually	RB	B-ADVP	O
resolved	resolve	VBN	B-VP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
failure	failure	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
March	March	NNP	I-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
:	:	:	O	O
RA	RA	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
.	.	.	O	O

Swan-Ganz	Swan-Ganz	JJ	B-NP	O
catheter	catheter	NN	I-NP	O
readings	reading	NNS	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
similar	similar	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-NP	O
respiratory	respiratory	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
as	as	IN	B-SBAR	O
opposed	oppose	VBN	B-VP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
nature	nature	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
course	course	NN	B-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
gentle	gentle	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
but	but	CC	O	O
proceeded	proceed	VBD	B-VP	O
to	to	TO	I-VP	O
aggressively	aggressively	RB	I-VP	O
manage	manage	VB	I-VP	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
eventually	eventually	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
regimen	regimen	NN	B-NP	O
of	of	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
hard	hard	JJ	B-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
left	leave	VBD	B-VP	O
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ranges	range	NNS	I-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
to	to	TO	B-PP	O
150s/40s	150s/40s	CD	B-NP	O
to	to	TO	B-PP	O
70s	70s	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
wise	wise	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
significant	significant	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
bronchospasm	bronchospasm	NN	B-NP	O
and	and	CC	O	O
slowly	slowly	RB	B-VP	O
improved	improve	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
begin	begin	VB	I-VP	O
the	the	DT	B-NP	O
taper	taper	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
until	until	IN	B-PP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
begin	begin	VB	I-VP	O
to	to	TO	I-VP	O
taper	taper	VB	I-VP	O
after	after	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	FW	B-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
after	after	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
Pulmonology	Pulmonology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
will	will	MD	B-VP	O
then	then	RB	I-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
needs	need	VBZ	B-VP	O
further	further	RBR	B-ADVP	O
tapering	taper	VBG	B-VP	O
and	and	CC	O	O
how	how	WRB	B-ADVP	O
fast	fast	RB	I-ADVP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Flovent	Flovent	NNP	B-NP	O
220	220	CD	I-NP	O
mcg	mcg	NN	I-NP	O
four	four	CD	B-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	VBN	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Advair	Advair	NN	B-NP	O
500/50	500/50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
inhalers	inhaler	NNS	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
Atrovent	Atrovent	JJ	I-NP	O
inhalers	inhaler	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
five	five	CD	B-NP	O
puffs	puff	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
for	for	IN	B-PP	O
followup	followup	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
,	,	,	O	O
552-3171	552-3171	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
fellow	fellow	NN	I-NP	O
input	input	NN	I-NP	O
was	be	VBD	B-VP	O
greatly	greatly	RB	I-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NNP	B-NP	B-protein
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
clot	clot	NN	B-NP	O
formation	formation	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
and	and	CC	O	O
then	then	RB	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

Should	Should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
ARVCA	ARVCA	NNP	B-NP	O
HEALTH	HEALTH	NNP	I-NP	O
NETWORK	NETWORK	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Onhop	Onhop	NNP	I-NP	O
Fants	Fant	NNPS	I-NP	O
Ho	Ho	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
draw	draw	VB	I-VP	O
her	her	PRP	B-NP	O
INR	INR	NNP	B-NP	O
first	first	RB	B-VP	O
starting	start	VBG	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
16	16	CD	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
issues	issue	NNS	I-NP	O
are	be	VBP	B-VP	O
creatinine	creatinine	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
bumped	bump	VBN	I-VP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
came	come	VBD	B-VP	O
down	down	RB	B-ADVP	O
steadily	steadily	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
discharge	discharge	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
good	good	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
major	major	JJ	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
low	low	JJ	I-NP	O
sodiums	sodium	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
persistently	persistently	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
levels	level	NNS	I-NP	O
as	as	IN	B-SBAR	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
infected	infect	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
visited	visit	VBN	I-VP	O
often	often	RB	B-ADVP	O
by	by	IN	B-PP	O
many	many	JJ	B-NP	O
family	family	NN	I-NP	O
members	member	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
follow-up	follow-up	NN	I-NP	O
appointments	appointment	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
disposition	disposition	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kent	Kent	NNP	I-NP	O
Odonal	Odonal	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
at	at	IN	B-PP	O
LISWOOD	LISWOOD	NN	B-NP	O
HEALTH	HEALTH	NN	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Roman	Roman	NNP	I-NP	O
Harrington	Harrington	NNP	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Electrophysiology	Electrophysiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
issues	issue	NNS	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
making	make	VBG	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Pulmonology	Pulmonology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
followup	followup	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
bronchospastic	bronchospastic	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
visiting	visit	VBG	I-VP	O
nurses	nurse	NNS	B-NP	O
'	'	POS	B-NP	O
support	support	NN	I-NP	O
setup	setup	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
connection	connection	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
DE	DE	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
essentially	essentially	RB	I-VP	O
improved	improve	VBN	I-VP	O
respiratory	respiratory	JJ	B-NP	O
wise	wise	JJ	I-NP	O
and	and	CC	I-NP	O
unchanged	unchanged	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
wise	wise	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
felt	feel	VBD	B-VP	O
ready	ready	JJ	B-ADJP	O
to	to	TO	B-VP	O
leave	leave	VB	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhalers	inhaler	VBZ	B-VP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Flovent	Flovent	NNP	B-NP	O
220	220	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Isordil	Isordil	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
simvastatin	simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
disposition	disposition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
again	again	RB	B-ADVP	O
needs	need	VBZ	B-VP	O
Pulmonary	Pulmonary	JJ	B-NP	O
followup	followup	NN	I-NP	O
and	and	CC	I-NP	O
appointment	appointment	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
fellow	fellow	NN	I-NP	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
form	form	VB	B-VP	O
the	the	DT	B-NP	O
Or-low	Or-low	NNP	I-NP	O
Chadi	Chadi	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-5739697	6-5739697	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
VENTERS	VENTERS	NNS	B-NP	O
,	,	,	O	O
LESLIE	LESLIE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GUEST	GUEST	NNP	B-NP	O
,	,	,	O	O
LESTER	LESTER	NNP	B-NP	O
KIRK	KIRK	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2512842	2512842	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/15/05	9/15/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/15/05	9/15/05	CD	B-NP	O

